Morgan Stanley

13F Holdings History for Evoke Pharma Inc - Common Stock (EVOK)

Symbol: EVOK on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 164K shares
Security Ownership: 10.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in Evoke Pharma Inc Common Stock (EVOK)

2025-09-08 - Morgan Stanley has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 164K shares of Evoke Pharma Inc Common Stock (EVOK). This represents 10.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Morgan Stanley	10.5%		$866K	164K			$5.29	13G	8/31/2025	8 Sep 2025 16:33:20

Holdings date	Weight	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	$166	64			$2.59	Q2 2025
3/31/2025	0%	$176	64	+33	+100%	$2.75	Q1 2025
12/31/2024	0%	$137	31			$4.42	Q4 2024
9/30/2024	0%	$148	31	+31	NEW	$4.77	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.